Delivery Order SPE2DB20D2104-SPE2DB25FMWTD
- Not listed
- The Defense Logistics Agency awarded a $4,126.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 22, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Candesartan Cilexetil is an angiotensin II receptor blocker commonly prescribed...
- The Defense Logistics Agency awarded a $40,296.55 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Candesartan Cilexetil 32 mg, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, non-set-aside contract executed under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The delivery order...
- The Defense Logistics Agency awarded a $1,506.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this contract represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.69 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units) with a firm fixed price structure. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation and represents a competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $15,002.49 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count units). This competitively awarded, non-set-aside contract employs firm fixed-price pricing and was executed on August 7, 2025, with an ultimate completion date of August 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at approximately $62,000 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90 count). The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,084.47 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 4 mg tablets in a quantity of 90-count units. This contract was awarded on July 18, 2025, under a firm fixed-price arrangement with an ultimate completion date of July 21, 2025. The award represents a non-competitive, non-set-aside delivery order and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Candesartan cilexetil is an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,485.26 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles) under a firm fixed-price contract. This competitively awarded delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a single transaction within DLA's pharmaceutical supply chain operations. The contract involves no set-aside designation and is being performed at...
- The Defense Logistics Agency awarded a $14,923.44 delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count) with a ceiling value of $53,240.96. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWTDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,163.90 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count units). This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a completion date of July 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Candesartan cilexetil is an angiotensin receptor blocker used for hypertension management, representing part of the company's ongoing pharmaceutical supply support to federal medical procurement needs. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor with significant federal contracting experience, AmerisourceBergen maintains a demonstrated capability to fulfill federal medical supply requirements through competitive procurement processes and serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/29/25 |